INR 393.0
(-0.57%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.32 Billion INR | -36.79% |
2022 | 2.19 Billion INR | -8.22% |
2021 | 2.39 Billion INR | 3.01% |
2020 | 2.32 Billion INR | 3.66% |
2019 | 2.23 Billion INR | 7.32% |
2018 | 2.08 Billion INR | 20.54% |
2017 | 1.73 Billion INR | 98.39% |
2016 | 872.68 Million INR | -4.54% |
2015 | 914.15 Million INR | 29.05% |
2014 | 708.38 Million INR | 8.79% |
2013 | 651.11 Million INR | 51.88% |
2012 | 428.7 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 FY | 1.38 Billion INR | -36.79% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 1.71 Billion INR | 0.0% |
2023 Q4 | 1.32 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 2.54 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 2.19 Billion INR | 0.0% |
2022 FY | 2.19 Billion INR | -8.22% |
2021 FY | 2.39 Billion INR | 3.01% |
2021 Q4 | 2.39 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 2.23 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q4 | 2.32 Billion INR | 0.0% |
2020 FY | 2.32 Billion INR | 3.66% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 2.24 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 2.23 Billion INR | 7.32% |
2019 Q2 | 2.12 Billion INR | 0.0% |
2019 Q4 | 2.22 Billion INR | 0.0% |
2018 Q4 | 2.08 Billion INR | 0.0% |
2018 FY | 2.08 Billion INR | 20.54% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 1.88 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q2 | 841.48 Million INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q4 | 1.73 Billion INR | 0.0% |
2017 FY | 1.73 Billion INR | 98.39% |
2017 Q1 | - INR | -100.0% |
2016 FY | 872.68 Million INR | -4.54% |
2016 Q4 | 872.68 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 707.81 Million INR | 0.0% |
2015 Q2 | 855.85 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 FY | 914.15 Million INR | 29.05% |
2015 Q4 | 887.96 Million INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2014 Q2 | 314.96 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 708.38 Million INR | 8.79% |
2014 Q4 | 708.38 Million INR | 0.0% |
2013 FY | 651.11 Million INR | 51.88% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 651.11 Million INR | 0.0% |
2013 Q2 | 348.16 Million INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2012 FY | 428.7 Million INR | 0.0% |
2012 Q4 | 428.7 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.35 Billion INR | 2.49% |
Biocon Limited | 162.76 Billion INR | 99.187% |
Blue Jet Healthcare Limited | 16.12 Million INR | -8100.304% |
Concord Biotech Limited | 97.37 Million INR | -1258.352% |
Dishman Carbogen Amcis Limited | 23.12 Billion INR | 94.28% |
GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
Lyka Labs Limited | 586.5 Million INR | -125.525% |
Panacea Biotec Limited | 209.9 Million INR | -530.162% |
SAMSRITA LABS LIMITED | 22.03 Million INR | -5903.581% |
Servoteach Industries Limited | 5059.00 INR | -26145561.198% |
SMS Lifesciences India Limited | 1 Billion INR | -31.32% |
Supriya Lifescience Limited | 54.88 Million INR | -2310.184% |
Syngene International Limited | 5.55 Billion INR | 76.176% |
TAKE Solutions Limited | 370.85 Million INR | -256.67% |
Titan Biotech Limited | 83.02 Million INR | -1493.069% |
Transgene Biotek Limited | 140.01 Million INR | -844.725% |
Vanta Bioscience Limited | 609.53 Million INR | -117.003% |